Sandra James has been re-elected as RCN Chair of Council, which represents almost 400,000 nurses and healthcare assistants across the UK, for a further two year term. Sandra is one of a number of Council Members who have been elected unopposed by RCN Council members to take up key Council officer roles following […]
Filed under: Nursing on October 5th, 2009 | No Comments »
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced the filing of a New Drug Submission (NDS) to Health Canada, the regulatory authority in Canada, for BEMA Fentanyl, also known as fentanyl buccal soluble film. BEMA Fentanyl is marketed in the U.S. as ONSOLIS, and the Canadian tradename is to be determined. BEMA Fentanyl was […]
Filed under: Cancer on October 5th, 2009 | No Comments »
In the first four months of the emergence of the latest strain of H1N1 influenza, more than 100 pregnant women infected with the virus needed hospitalization in intensive care units, and 28 died, the Washington Post reports. The deaths occurred between late April, when the new strain appeared, and the end of August.
More: continued […]
Filed under: Pregnancy on October 5th, 2009 | No Comments »
Virginia Commonwealth University researchers have identified the role of a gene in regulating molecular signals involved with ovarian follicle development, which may one day help shed light on some of the causes of fertility issues in humans. The steps involved with conception and pregnancy are delicate and complex - particularly […]
Filed under: Biology on October 5th, 2009 | No Comments »
New findings, published in the journal Science, about the bacteria Wolbachia could be used to control mosquito populations and prevent malaria, dengue fever and other mosquito-borne diseases,
More: continued here
Filed under: Infectious Diseases / Bacteria / Viruses on October 5th, 2009 | No Comments »
A change in the reimbursement rate for the drug Avastin, used off-label to treat an eye illness in the elderly, could lead Medicare doctors to use a much costlier drug that would cost the system millions, The New York Times reports.
More: continued here
Filed under: Eye Health on October 5th, 2009 | No Comments »
AFRESA® (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, showed no significant changes in pulmonary function and sustained glycemic control in adult patients with type 2 diabetes over four years of continuous treatment, according to data presented today at the 45th Annual Meeting of the European Association for the Study of […]
Filed under: Clinical Trials on October 5th, 2009 | No Comments »
A new study by an international team of researchers found that cholesterol is important for the formation of brain cells, and they hope the findings will help scientists cultivate dopamine-producing cells outside the body.
More: continued here
Filed under: Cholesterol on October 5th, 2009 | No Comments »
The following summarizes selected women’s health-related blog entries. ”
More: continued here
Filed under: Cervical Cancer on October 5th, 2009 | No Comments »
The GP Patient Survey is a reliable and valid way of providing financial incentives to doctors, and there is little evidence to support concerns that it has led to unfair payments, according to new research published on bmj.com today. The GP Patient Survey is part of the Government’s commitment to make […]
Filed under: Primary Care on October 5th, 2009 | No Comments »